Coherus Biosciences | CHRS - Ordinary Share Capital


Coherus Biosciences reported $121.16M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Acadia Pharmaceuticals USD 169.18M 470K Dec/2025
Akebia Therapeutics USD 265.42M 199K Dec/2025
ALKERMES USD 165.61M 503K Dec/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
Amarin USD 20.81M 13K Dec/2025
Amgen USD 539M 1000K Dec/2025
Baxter International USD 514.28M 168.72M Dec/2025
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Coherus Biosciences USD 121.16M 4.92M Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Fujifilm JPY 1.21B 19K Dec/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
Merck USD 2.49B 15.79M Sep/2025
Myriad Genetics USD 93.5M 400K Dec/2025
Pacira USD 41.12M 1.85M Dec/2025
Perrigo USD 137.6M 0 Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Sarepta Therapeutics USD 104.96M 196K Dec/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025
Vertex Pharmaceuticals USD 254M 0 Dec/2025
Xencor USD 71.87M 529K Dec/2025
Zoetis USD 424.93M 16.54M Dec/2025